Demonstrating chemo without hair loss is possible
Hair loss is the most traumatic side effect of cancer treatment. Lily is a therapy in development that is intended to prevent hair loss caused by chemotherapy using a novel treatment modality. Our initial data shows that Lily can prevent hair loss through multiple cycles of chemotherapy treatment, while control patients experience 100% hair loss. To see the full dataset, enter investor credentials below.
Preventing peripheral neuropathy: the #1 cause of discontinuation for new-wave anti-body drug conjugates
Lilac is an early clinical stage therapy intended to prevent peripheral neuropathy caused by chemotherapy and anti-body drug conjugates using the same treatment modality as Lily. Initial independent investigator-led studies of the Lilac treatment parameters have shown >90% of patients experiencing a reduction in CIPN symptoms when treated. To see the full dataset, enter investor credentials below.
